Ibsen Biotechnology Co., Ltd
Reborn Biological terminal brand company, Ibsen Biotechnology Co., Ltd., is a high-tech biotechnology enterprise that focuses on the research and development, production, and sales of healthy food. Adhering to the mission of using the company platform as the carrier, precision targeting as the guide, bioactive peptides as the core, and intervention and prevention as the original intention, its products are mainly used for delaying human aging, skin care, Qi and blood dual nourishment, joint nutrition, liver and lung protection, and enhancing immunity and other health benefits. To provide high-quality services for the vast number of health demanders, provide a platform and development foundation for participants in the health industry, and strive to build a health ecosystem and health big data, driving an effective cycle of capital empowerment and value replenishment. In terms of R&D, the company has invested an average of more than 10 million yuan every year. There are more than 20 invention patents, 17 invention patents have been accepted, and more than 40 full-time R&D technicians (including 5 doctors and 11 masters). The company has established close cooperation relations with Fudan University, Huazhong Agricultural University, Hubei University of Technology and other universities, and signed R&D cooperation agreements, laying a solid foundation for the company to maintain technological progressiveness in the future. Under the leadership of the chairman, the company adheres to the business philosophy of "do not do to others what you do not want", continues to deeply cultivate the bioactive peptide industry, and creates the world's largest high-quality bioactive peptide industry park, contributing to the revitalization of China's national industry and the cause of human health with the efforts of Reborn people themselves.
